Tokyo, Sept. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059043) titled 'Research on Novel Biomarkers and Therapeutic Target Molecules for Urological Cancers' on Sept. 15.
Study Type:
Observational
Primary Sponsor:
Institute - Fukushima Medical University
Condition:
Condition - Genitourinary Cancer
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - Urological cancers, including renal cell carcinoma, urothelial carcinoma of the renal pelvis and bladder, testicular cancer, and prostate cancer, are generally considered to have more favorable prognoses compared with many other malignancies. However, for patients who are not candidates f...